logo-loader
FinanceBanks
JPMorgan Chase & Co

JPMorgan and the German government squash rumors of a potential investment in Deutsche Bank

A weekly German publication alleged that JPMorgan and a Chinese bank were going to invest in Deutsche Bank

Deutsche Bank
The US bank and the German government have both denied the claims

Rumors have been swirling around JPMorgan Chase & Co (NYSE:JPM) and Deutsche Bank (NYSE:DB), suggesting that the US bank was interested in a stake in the German giant.

German magazine WirtschaftsWoche said that JPMorgan and the Industrial and Commercial Bank of China were interested in investing in Deutsche Bank, according to a Reuters report.

The publication alleged that Chancellor Angela Merkel met with Alex Weber, the chairman of Swiss bank UBS and the former head of Bundesbank.

JPMorgan and the German government have squashed the gossip, stating that there is no truth to the claims.

"We are denying the story, it is not true,” stated a JPMorgan spokeswoman.

"We were astonished to learn about the report about a supposed conversation between the chancellor and Mr. Weber. It is purely speculative and cannot be confirmed,” said government spokesman Steffen Seibert in a news conference.

Seibert added that the German government has full trust in the flagship bank.

Shares of JPMorgan were up slightly to US$104.45 while shares of Deutsche Bank were up nearly 4% to US$11.52 in Friday pre-market trading.

 

Contact Lenore Fedow at [email protected]

Follow her on Twitter@LenoreMariee

Quick facts: JPMorgan Chase & Co

Price: $108.75

Market: NYSE
Market Cap: $347.73 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Bevcanna receives Health Canada licence for Research

BevCanna (CSE: BEV) Chief Commercialization Officer Emma Andrews sat down with Proactive Vancouver’s Steve Darling with news the company has received their research licence with from Health Canada. The newly-granted license allows BevCanna to test cannabinoid infusion equipment on their bottling...

4 hours, 49 minutes ago

2 min read